Market Place
Sourcing Support
Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016
This week, PharmaCompass
reviews the recently released data on prescription drugs paid for under th
Dead fish in Hyderabad puts pharma majors under scrutiny; False data uncovered in AstraZeneca’s US$ 4 billion buy
This week, Phispers has news from across the world. While China is trying to speed up approval of dr
FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More
After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the
President of the United States. He
